Results 51 to 60 of about 41,122 (231)

Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study

open access: yesAnnals of Clinical Microbiology and Antimicrobials, 2010
Background The frequency of primary resistance to antibiotics in H. pylori isolates is increasing worldwide. In Tunisia, there are limited data regarding the pattern of H. pylori antibiotic primary resistance. Aim To evaluate the primary resistance of H.
Ben Mansour Khansa   +21 more
doaj   +1 more source

Unsupervised machine learning for multi‐system adverse event pattern detection in pharmacovigilance: A proof‐of‐concept analysis of fluoroquinolone reports in FAERS

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
. Aims Traditional pharmacovigilance detects single drug–event associations but cannot readily characterize multi‐system adverse‐event patterns such as fluoroquinolone‐associated disability. We evaluated unsupervised machine learning for this purpose, using fluoroquinolones as an exemplar.
Niaz Chalabianloo   +3 more
wiley   +1 more source

Update on clarithromycin resistance in Helicobacterpylori in Hong Kong and its effect on clarithromycin-based triple therapy

open access: yes, 2005
Aim To update the antibiotic susceptibility of Helicobacter pylori andevaluate the efficacy of a clarithromycin-based triple therapy in rela-tion to metronidazole and/or clarithromycin resistance in Hong Kong.
Gu, Q   +11 more
core   +1 more source

Incidence and impact of respiratory tract infections on outcomes in patients with status epilepticus: A 20‐year longitudinal observation

open access: yesEpilepsia, EarlyView.
Abstract Objective This study was undertaken to identify the incidence of respiratory tract infections (RTIs) in a large cohort of adult patients with status epilepticus (SE) and to characterize their associations with clinical features and outcome determinants.
Sebastian Berger   +8 more
wiley   +1 more source

Challenges for interpreting results of antimicrobial susceptibility testing for treating infections of foals with Rhodococcus equi

open access: yesEquine Veterinary Journal, EarlyView.
Abstract Rhodococcus equi is a facultative intracellular pathogen and a major cause of pneumonia in foals worldwide. The standard treatment for affected foals is a combination of a macrolide with rifampicin. The widespread use of this combination has led to the emergence of multidrug‐resistant (MDR) strains of R. equi.
Marlane Geribone Seeger   +7 more
wiley   +1 more source

Immediate reaction to clarithromycin

open access: yesAllergologia et Immunopathologia, 2001
We present the case of bronchospastic reaction to clarithromycin had during a drug challenge test. Personal allergic history was negative for respiratory allergies and positive for adverse drug reactions to general and regional anesthesia and to ceftriaxone.
GANGEMI, Sebastiano   +4 more
openaire   +3 more sources

Clarithromycin induced reversible sensorineural hearing loss

open access: yesB-ENT, 2011
Clarithromycin induced reversible sensorineural hearing loss. Objective: We present a rare case of reversible sensorineural hearing loss caused by clarithromycin.
J. K. Hajiioannou   +4 more
doaj   +2 more sources

Short Course Monotherapy with Clarithromycin for Localized Mycobacterium Marinum Skin Infection

open access: yesCanadian Journal of Infectious Diseases, 1997
In vitro studies have shown that Mycobacterium marinum is usually susceptible to clarithromycin. However, there are limited published data on the clinical use of clarithromycin for the treatment of M marinum infections. This report describes a previously
Mitchell R Weinstein   +2 more
doaj   +1 more source

Clarithromycin-resistant Helicobacter pylori in Recife, Brazil, directly identified from gastric biopsies by polymerase chain reaction

open access: yesArquivos de Gastroenterologia, 2010
CONTEXT: Clarithromycin is the most effective drug used in the eradication of infection by Helicobacter pylori. Due to worldwide increase in resistance, pre-treatment susceptibility testing for clarithromycin is recommended.
Ana Kelly Lins   +2 more
doaj   +1 more source

Is Less More? An Update on Aspirin for Cancer Prevention in Lynch Syndrome From the Cancer Prevention Programme—CaPP

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT Aspirin has been used to treat pain and fever for 120 years. Its uses expanded into treating arthritis and prevention of thrombotic events. Its anti‐cancer role emerged with observational studies in the 1980's and subsequent cancer review in those treated with aspirin in cardiovascular trials.
John Burn, D. Timothy Bishop
wiley   +1 more source

Home - About - Disclaimer - Privacy